Optimizing the treatment for advanced non–small-cell lung cancer with mutated epidermal growth factor receptor in low-income countries: a review
Introduction Osimertinib is the treatment of choice for epidermal growth factor receptor
(EGFR)-mutated advanced non–small-cell lung cancer (NSCLC). Because of its high price …
(EGFR)-mutated advanced non–small-cell lung cancer (NSCLC). Because of its high price …
[HTML][HTML] Optimizing the Treatment for Advanced Non–Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review
M Alali, M Saifo - Journal of Immunotherapy and Precision …, 2023 - ncbi.nlm.nih.gov
Methods An electronic literature search was conducted of published phase II and III studies
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …
Optimizing the Treatment for Advanced Non–Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review
M Alali, M Saifo - Journal of Immunotherapy and Precision Oncology, 2023 - europepmc.org
Methods An electronic literature search was conducted of published phase II and III studies
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …
Optimizing the Treatment for Advanced Non-Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review
M Alali, M Saifo - Journal of immunotherapy and precision …, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction Osimertinib is the treatment of choice for epidermal growth factor receptor
(EGFR)-mutated advanced non-small-cell lung cancer (NSCLC). Because of its high price …
(EGFR)-mutated advanced non-small-cell lung cancer (NSCLC). Because of its high price …
Optimizing the Treatment for Advanced Non-Small-Cell Lung Cancer with Mutated Epidermal Growth Factor Receptor in Low-Income Countries: A Review.
M Alali, M Saifo - Journal of Immunotherapy and Precision Oncology, 2023 - europepmc.org
Methods An electronic literature search was conducted of published phase II and III studies
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …
that assessed the efficacy of EGFR-TKIs for advanced NSCLC between January 2003 and …